000 01154 a2200313 4500
005 20250512030036.0
264 0 _c19880601
008 198806s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.32.2.257
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKuo, C C
245 0 0 _aIn vitro drug susceptibility of Chlamydia sp. strain TWAR.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cFeb 1988
300 _a257-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAmpicillin
_xpharmacology
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aChlamydia
_xdrug effects
650 0 4 _aErythromycin
_xpharmacology
650 0 4 _aHumans
650 0 4 _aPenicillin G
_xpharmacology
650 0 4 _aSpectinomycin
_xanalogs & derivatives
650 0 4 _aSulfisoxazole
_xpharmacology
650 0 4 _aTetracycline
_xpharmacology
700 1 _aGrayston, J T
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 32
_gno. 2
_gp. 257-8
856 4 0 _uhttps://doi.org/10.1128/AAC.32.2.257
_zAvailable from publisher's website
999 _c2972449
_d2972449